Published 2 months ago • loading... • Updated 2 months ago

Moderna Scales Down Manufacturing

Summary by Inc.

The biotech giant reported a bigger-than-expected quarterly loss.

7 Articles

All

Left

Center

Right

Inc.

Center

Moderna Scales Down Manufacturing

The biotech giant reported a bigger-than-expected quarterly loss.

2 months ago

Read Full Article

The Motley Fool

Lean Left

Moderna's Q4 Loss Wider Than Expected @themotleyfool #stocks $MRNA

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.

2 months ago·Alexandria, United States

Read Full Article

CNBC

Reposted by

Stockxpo - A professional network of traders, investors and analysts

Center

Moderna beats on revenue but loses more than expected as it scales down manufacturing

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

2 months ago·United States

Read Full Article

Seeking Alpha

Lean Right

Moderna GAAP EPS of -$2.91 misses by $0.15, revenue of $966M beats by $24.86M (NASDAQ:MRNA)

Moderna (MRNA) reports Q4 GAAP EPS of -$2.91, misses by $0.15, but beats revenue estimates with $966M.

2 months ago·United States

Read Full Article

Busines and Oil News

Moderna beats on revenue but loses more than expected as it scales down manufacturing – DG Verifications & Stats

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNTThe Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024.Adam Glanzman | Bloomberg | Getty Images Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, wh…

2 months ago

Read Full Article

Daily News Update

Moderna beats on revenue but loses more than expected as it scales down manufacturing - Daily news Update

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline of its once-booming Covid business. Shares of Moderna fell more than 4% in premarket trading Friday. Moderna post…

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year